Tempest Therapeutics, Inc. Deferred Tax Assets, Operating Loss Carryforwards
Tempest Therapeutics, Inc. (TPST) had Deferred Tax Assets, Operating Loss Carryforwards of $152.07 million as of 2025-12-31, per its 10-K filed 2026-03-30.
Financial Statements › Notes › Income Taxes › Components of Deferred Tax Assets and Liabilities › Components of Deferred Tax Assets › Deferred Tax Assets, Net › Deferred Tax Assets, Net of Valuation Allowance › Deferred Tax Assets, Gross › Deferred Tax Assets, Operating Loss Carryforwards, Components
us-gaap:DeferredTaxAssetsOperatingLossCarryforwards · last filed 2026-03-30
- 2025-12-31: Deferred Tax Assets, Operating Loss Carryforwards $152.07M.
- 2024-12-31: Deferred Tax Assets, Operating Loss Carryforwards $143.90M.
- 2023-12-31: Deferred Tax Assets, Operating Loss Carryforwards $136.90M.
- 2022-12-31: Deferred Tax Assets, Operating Loss Carryforwards $131.35M.
| Period end | Deferred Tax Assets, Operating Loss Carryforwards | Deferred Tax Assets, Operating Loss Carryforwards as first filed |
|---|---|---|
| 2025-12-31 | $152.07M 10-K · filed 2026-03-30 | |
| 2024-12-31 | $143.90M 10-K · filed 2026-03-30 | |
| 2023-12-31 | $136.90M 10-K · filed 2025-03-27 | |
| 2022-12-31 | $131.35M 10-K · filed 2024-03-19 | |
| 2021-12-31 | $125.11M 10-K · filed 2023-03-22 | |
| 2020-12-31 | $23.94M 10-K · filed 2022-03-29 | $90.84M 10-K · filed 2021-03-29 |
| 2019-12-31 | $96.38M 10-K · filed 2021-03-29 | |
| 2018-12-31 | $87.45M 10-K · filed 2020-03-11 | |
| 2017-12-31 | $20.98M 10-K · filed 2019-04-01 | $53.23M 10-K · filed 2018-03-15 |
| 2016-12-31 | $53.65M 10-K · filed 2018-03-15 | |
| 2015-12-31 | $36.13M 10-K · filed 2017-03-02 | |
| 2014-12-31 | $26.13M 10-K · filed 2016-02-26 | |
| 2013-12-31 | $12.94M 10-K · filed 2015-03-16 | |
| 2012-12-31 | $5.53M 10-K · filed 2014-02-27 | |
| 2011-12-31 | $750.00K 10-K · filed 2013-02-25 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Aspire Biopharma Holdings, Inc. (ASBP) | United States | $0.012B | -0.60 |
| AEON Biopharma, Inc. (AEON) | United States | $0.013B | -0.36 |
| BIOVIE INC. (BIVI) | United States | $0.012B | |
| MUSTANG BIO, INC. (MBIO) | United States | $0.013B | |
| Vistagen Therapeutics, Inc. (VTGN) | United States | $0.013B | -0.14 |
| ADIAL PHARMACEUTICALS, INC. (ADIL) | United States | $0.012B | |
| Phio Pharmaceuticals Corp. (PHIO) | United States | $0.012B | -0.92 |
| Scienture Holdings, Inc. (SCNX) | United States | $0.012B | -0.38 |
| LISATA THERAPEUTICS, INC. (LSTA) | United States | $0.014B | -2.13 |
| KIORA PHARMACEUTICALS INC (KPRX) | United States | $0.012B |